Sweden
Norway
Denmark
Finland
IcelandWelcome colleagues
The Norwegian Society of Hematology is happy to invite you to the 42nd Nordic Hematology Spring Meeting, which will be hosted in the city of Bergen, Norway from Wednesday May 4th to Friday May 6th 2011.
TUESDAY 3rd of May
| 19:00-21:00 |
|---|
WEDNESDAY 4th of May
| FIRST MORNING SESSION |
08.15-10.00 |
|
|---|---|---|
| Acute myeloid leukemia |
||
| Chairman: Bjørn Tore Gjertsen |
||
| 08.15-09.00 |
The MRC experience in treatment of AML |
Alan K Burnett, Cardiff |
| 09.00-09.45 |
The HOVON experience in treatment of AML |
Bob Löwenberg, Rotterdam |
| 09.45-10.00 |
Targeted therapy in human AML |
Søren Lehman, Stockholm |
| COFFEE BREAK, EXHIBITIONS |
10.00-10.30 |
| SPONSORED SYMPOSIUM INCL. LUNCH |
10.30-13.30 |
|
|---|---|---|
| Hosted by Mundipharma/norpharma |
||
| Opening |
||
| 10:30-10:35 |
Opening of the meeting |
G Tjønnfjord |
| 10:35-11:00 |
Impact a highly effective anti-leukemia and anti-lymphoma drug makes: Where it works, How it works and Why it works |
L Leoni |
| 11:00-11:30 |
News on the clinical activity of Bendamustine in CLL |
W Knauf |
| 11:30-12:00 |
New perspectives in indolent lymphomas with Bendamustine |
M Rummel |
| 12:00-12:30 |
Coffee break & Lunch bag ‘pick up’ |
|
| 12:30-13:15 |
The potential of Levact® in B-cell malignancies |
B Cheson |
| Q&A and Closure |
||
| 13:15-13:30 |
Q&A and closure of the symposium |
G Tjønnfjord |
| EARLY AFTERNOON |
13.30-15.00 |
|
|---|---|---|
| Thromboembolic diseases |
||
| Chairman: Per Morten Sandset |
||
| 13.30-14.10 |
Heparin-induced thrombocytopenia |
Andreas Greinacher, Greifswald |
| 14.10-14.35 |
An update on the diagnosis of venous thrombosis |
Henry Eriksson, Gøteborg |
| 14.35-15.00 |
An update on the treatment of venous thrombosis |
Per Morten Sandset, Oslo |
| COFFEE BREAK, EXHIBITIONS |
15.00-15.20 |
| LATE AFTERNOON SESSION |
15.20-16.50 |
|
|---|---|---|
| Platelet transfusions |
||
| Chairman: Tor Hervig |
||
| 15.20-16.05 |
A road to clinical improvement – towards the optimal platelet concentrate |
Pieter van der Meer, |
| 16.05-16.50 |
How to evaluate the effects of platelet transfusions |
Tor Hervig, Bergen |
| SPONSORED SYMPOSIUM |
17.00-18.30 |
|
|---|---|---|
| Hosted by Novartis |
||
| Chairmen : Tobias Gedde-Dahl/Henrik Hjorth Hansen |
||
| 17:00-17:15 |
Patient Case: Sub-optimal response on imatinib, consideration when choosing 2nd line treatment. |
Dr. Tobias Gedde-Dahl, Oslo University Hospital - Rikshospitalet Campus |
| 17:15-17:45 |
1st line treatment of CML-several choices. What will be the deciding factor for choice of treatment? |
Prof. Giuseppe Saglio, University of Turin, Orbassano, Italy |
| 17:50-18:10 |
‘Iron chelation in heavily transfused patients with MDS. What is the benefit?’ |
Prof. Norbert Gattermann, Heinrich Heine University of Düsseldorf, Germany |
| 18:10-18.30 |
‘Iron overload in patients undergoing HSCT. A cause for concern?’ |
Prof. Norbert Gattermann, Heinrich Heine University of Düsseldorf, Germany |
| Novartis Reception at Scandic Bergen City Hotel (conference venue) |
18:30-19:30 |
THURSDAY 5th of May
| THURSDAY MORNING |
08.30-10.15 |
|
|---|---|---|
| The elderly cancer patient |
||
| Chairman: Stein Kaasa |
||
| 08.30-09.00 |
Palliative treatment in elderly cancer patients |
Stein Kaasa, Trondheim |
| 09.00-09.30 |
Palliation, disease stabilization and quality of life in elderly patients with haematological malignancies |
Finn Wisløff, Oslo |
| 09.30-10.00 |
Treatment of elderly patients with chronic lymphocytic leukemia |
Michael Hallek, Køln |
| COFFEE BREAK, EXHIBITIONS |
10.00-10.30 |
| THURSDAY MIDDAY |
10.30-12.00 |
|
|---|---|---|
| Lymphoproliferative diseases |
||
| Chairman: Olav Mella |
||
| 10.30-10.50 |
Impact of radiotherapy in diffuse large B-cell lymphoma: |
Øystein Fluge, Bergen |
| 10.50-11.30 |
Impact of radiotherapy in diffuse large B cell lymphoma: a review |
Carsten Nieder, Bodø |
| 11.30-12.00 |
Diagnosis and treatment of cold agglutinin disease-the current status |
Sigbjørn Berentsen Haugesund |
| LUNCH BREAK, EXHIBITIONS |
12.00-13.30 |
|
PER MAGNE UELAND, BERGEN
|
13.30-14.30 |
| THURSDAY AFTERNOON |
14.30-15.30 |
|
|---|---|---|
| Myeloid malignancies |
||
| Chairman: Øystein Bruserud |
||
| 14.00-14.30 |
Allogeneic retransplantation for acute leukemia |
Tapani Ruutu, Helsinki |
| 14.30-15.00 |
Allogeneic stem cell transplantation in elderly: is it feasible and effective? |
Alois Grathwohl, Basel |
| COFFEE BREAK, POSTER VIEWING, EXHIBITIONS |
15.30-16.00 |
| ANNUAL MEETING NORDIC SOCIETY FOR HEMATOLOGY |
16.00-17.00 |
| DINNER-FLØIEN Conference Dinner at Mt Fløien |
19.00 |
FRIDAY 6th of May
| FRIDAY EARLY MORNING |
08.15-10.30 |
|
|---|---|---|
| Curative drug therapy for chronic myeloid leukemia |
||
| Chairman: Kimmo Porkka |
||
| 08.15-08.45 |
CML therapy – an overview |
Henrik Hjorth-Hansen, Trondheim |
| 08.45-09.30 |
Insights from drug discontinuation studies in CML. |
Jesper Stentoft, Arhus |
| 09.30-10.00 |
Restoring anti-CML immunity |
Kimmo Porkka, Helsinki |
| 10.00-10.30 |
Stem cell targeting: essential for cure? |
Johan Richter, Lund |
| 10.30-11.00 |
COFFEE BRAKE, EXHIBITIONS |
|
| FRIDAY MIDDAY |
11.00-12.30 |
|
|---|---|---|
| Future perspectives |
||
| Chairman: Øystein Bruserud |
||
| 11.00-11.45 |
Immunological host-fungus interactions and the possibilities |
Stig Frøland, Oslo |
| 11.45-12.30 |
Haploidentical stem cell transplantation |
Stephan Mielke, Würtzburg |
| LUNCH |
12.30 |
Print page
